Clustering Microsoft Windows Executables based on TF-IDF and API Information
Research Briefs on Information and Communication Technology Evolution · 2016
DOI: 10.56801/rebicte.v2i.35 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Briefs on Information and Communication Technology Evolution, 2016. Verfasst von Jonghwa Park und 3 weiteren Autor:innen.
Abstract (Originalsprache)
The illegal software usage is 39% worldwide and malware is frequent in the illegal software. Toprotect attacks from malware, we use software filtering. The software filtering compares equivalenceof a testing software to an original one. This requires comparison between all the legal programs inthe market. So we have to reduce the number of comparisons by clustering programs in the market.Every market provides categories to programs such as image viewer, video player, audio player, andmessenger, etc. But it is not clear that these categories are best fit to filter malware. We suggest newcategories which are more suitable to classification experimentally. Our categories are automaticallymade from the K-means clustering algorithm based on TF-IDF and API information. Experimentalresults show that our clustering scheme is better than the existing categories to classify malware.
Zitieren
APA
Park, J., Kim, G., Hwang, Y., & Cho, S. (2016). Clustering Microsoft Windows Executables based on TF-IDF and API Information. Research Briefs on Information and Communication Technology Evolution. https://doi.org/10.56801/rebicte.v2i.35
Vancouver
Park J, Kim G, Hwang Y, Cho S. Clustering Microsoft Windows Executables based on TF-IDF and API Information. Research Briefs on Information and Communication Technology Evolution. 2016. doi:10.56801/rebicte.v2i.35
BibTeX
@article{Park2016,
author = {Park, Jonghwa and Kim, Gyoosik and Hwang, Youngsup and Cho, Seong-je},
title = {Clustering Microsoft Windows Executables based on TF-IDF and API Information},
journal = {Research Briefs on Information and Communication Technology Evolution},
year = {2016},
doi = {10.56801/rebicte.v2i.35}
}
EUVIMED